★★★★

Wing's Foot

Wings Foot Q1 sales plunge 79%, operating loss 4.4 bn won, net loss continues


  • Q1 2026 sales: 1.45 bn won (down 79% YoY from 7.07 bn)
  • Operating loss: 4.43 bn won (vs operating loss of 0.82 bn won in Q1 2025)
  • Net loss: 7.16 bn won (similar to Q1 2025 net loss of 7.07 bn, persistent large loss)
  • Debt ratio: 94.2% (up from 72.8% at year-end 2025), equity: 24.37 bn (down from 31.53 bn)
  • CB (face value 10 bn won) put option exercisable from Apr 30, 2026, increasing liquidity risk
  • Financial costs of 2.87 bn won (including derivative losses) worsen net loss
  • Cash: 4.43 bn won, short-term borrowings: 0.34 bn, limited liquidity

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: Wing's Foot (335870)
  • Submission: Wing's Foot Inc.
  • Receipt: 05-14-2026